Latest News

As part of our ’25 at 25’ series, we explore how the OCTOPUS trial in progressive multiple sclerosis (MS) aims to speed up the delivery of new treatments, bringing hope to the MS community.
As part of our ’25 at 25’ series, we look back at The SHINE trial, which was the first randomised controlled trial to assess the length of treatment needed for children with TB.